Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruoji Zhou

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Surgical Pathology|March 13, 2025
Adenomatoid Tumor of the Liver with Prominent Admixed Cavernous Hemangioma-Like Vessels: An Exceptional OccurrenceRuoji Zhou, Hanlin L Wang
Trends in Cancer|October 11, 2016
Modeling Cancer with Pluripotent Stem CellsJulian Gingold, Ruoji Zhou, Ihor R Lemischka, et al.
Virchows Archiv : an International Journal of Pathology|April 15, 2014
Invasive breast carcinomas of no special type with osteoclast-like giant cells frequently have a luminal phenotypeShuling Zhou, Lin Yu, Ruoji Zhou, et al.
Annals of Diagnostic Pathology|May 22, 2026
Assessment of delta-like ligand 3 (DLL3) immunostaining in neuroendocrine tumors of the gynecological tract and comparing expression with other high-grade gynecological malignanciesMaggie Tsang, Ruoji Zhou, Yuna Kang, et al.
Journal of Cancer|February 28, 2018
Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancerShuling Zhou, Xiangjie Sun, Lin Yu, et al.
Trends in Pharmacological Sciences|August 19, 2017
Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53Ruoji Zhou, An Xu, Julian Gingold, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem CellsRuoji Zhou, An Xu, Jian Tu, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2014
Male breast carcinoma: a clinicopathological and immunohistochemical characterization studyRuoji Zhou, Lin Yu, Shuling Zhou, et al.
BMC Cancer|August 10, 2014
CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signalingYayun Chi, Sheng Huang, Lei Wang, et al.
Pathology, Research and Practice|March 21, 2025
Clinicopathologic analysis and digital pathology evaluation of orchiectomy specimens in gender-affirmation surgeryIvan De La Riva-Morales, Alcino Gama, Ruoji Zhou, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Surgical Pathology|March 13, 2025
Adenomatoid Tumor of the Liver with Prominent Admixed Cavernous Hemangioma-Like Vessels: An Exceptional OccurrenceRuoji Zhou, Hanlin L Wang
Trends in Cancer|October 11, 2016
Modeling Cancer with Pluripotent Stem CellsJulian Gingold, Ruoji Zhou, Ihor R Lemischka, et al.
Virchows Archiv : an International Journal of Pathology|April 15, 2014
Invasive breast carcinomas of no special type with osteoclast-like giant cells frequently have a luminal phenotypeShuling Zhou, Lin Yu, Ruoji Zhou, et al.
Annals of Diagnostic Pathology|May 22, 2026
Assessment of delta-like ligand 3 (DLL3) immunostaining in neuroendocrine tumors of the gynecological tract and comparing expression with other high-grade gynecological malignanciesMaggie Tsang, Ruoji Zhou, Yuna Kang, et al.
Journal of Cancer|February 28, 2018
Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancerShuling Zhou, Xiangjie Sun, Lin Yu, et al.
Trends in Pharmacological Sciences|August 19, 2017
Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53Ruoji Zhou, An Xu, Julian Gingold, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem CellsRuoji Zhou, An Xu, Jian Tu, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2014
Male breast carcinoma: a clinicopathological and immunohistochemical characterization studyRuoji Zhou, Lin Yu, Shuling Zhou, et al.
BMC Cancer|August 10, 2014
CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signalingYayun Chi, Sheng Huang, Lei Wang, et al.
Pathology, Research and Practice|March 21, 2025
Clinicopathologic analysis and digital pathology evaluation of orchiectomy specimens in gender-affirmation surgeryIvan De La Riva-Morales, Alcino Gama, Ruoji Zhou, et al.
Pageof 3